Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-17-010644)

Filing Details

Accession Number:: 0001140361-17-010644
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-03-03 19:40:17
Reporting Period:: 2017-03-03

Filing Date:: 2017-03-03
Accepted Time:: 2017-03-03 19:40:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1437402	Ardelyx Inc.	ARDX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1626854	S Jeremy Caldwell	C/O Ardelyx, Inc. 34175 Ardenwood Blvd, Suite 200 Fremont CA 94555	Evp, Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-03-03	1,026	$14.14	17,985	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Consists of 1,026 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2017.
Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.